Soleus Capital Management, L.P. has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $1.29 Billion distributed in 95 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Krystal Biotech, Inc. with a value of $127M, Novo Cure LTD with a value of $123M, Tg Therapeutics, Inc. with a value of $80.8M, United Therapeutics Corp with a value of $60.3M, and Grifols Sa with a value of $52M.

Examining the 13F form we can see an increase of $81.7M in the current position value, from $1.21B to 1.29B.

Soleus Capital Management, L.P. is based out at Greenwich, CT

Below you can find more details about Soleus Capital Management, L.P. portfolio as well as his latest detailed transactions.

Portfolio value $1.29 Billion
Healthcare: $1.22 Billion
ETFs: $62.2 Million
Industrials: $9.88 Million
Consumer Defensive: $1.91 Million

Stock Holdings Table Companies Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 95
  • Current Value $1.29 Billion
  • Prior Value $1.21 Billion
  • Filing
  • Period Q2 2025
  • Filing Date August 14, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 27 stocks
  • Additional Purchases 19 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 27 stocks
Track This Portfolio

Track Soleus Capital Management, L.P. Portfolio

Follow Soleus Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Soleus Capital Management, L.P. with notifications on news.